Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Intermittent Fasting 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Overweight 1Obesity 1Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Trastuzumab 628Paclitaxel 577Cyclophosphamide 555Docetaxel 485Capecitabine 402Letrozole 376Fulvestrant 327Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 186Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 139Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Neoplasms × Diet, Healthy × Clear all
NCT01525264 2016-08-18

Breast Cancer Screening Intervention

Jonsson Comprehensive Cancer Center

Phase NA Completed
434 enrolled
Breast

Breast Neoplasms

NCT01304251 2016-01-12

Effects of Short-term Fasting on Tolerance to Chemotherapy

Leiden University Medical Center

Phase NA Completed
13 enrolled
Breast

Intermittent Fasting, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡